MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
12 hedge funds and large institutions have $5.32M invested in Merrimack Pharmaceuticals, Inc. in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-58
Holders Change %
-82.86%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
2
Reduced
2
Closed
62
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$1.82M
Top Buyers
| 1 |
Goldman Sachs
New York
|
$451K |
| 2 |
JC
JBF Capital
Aspen,
Colorado
|
$1.19K |
| 3 |
Marshall Wace
London,
United Kingdom
|
$1.15K |
